Ciprofloxacin extended release side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Ciprofloxacin extended release. Common side effects include tendonitis among males.

The phase IV clinical study is created by eHealthMe based on 20 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 16, 2023

20 people who take Ciprofloxacin Extended Release and have side effects are studied.


What is Ciprofloxacin Extended Release?

Ciprofloxacin extended release has active ingredients of ciprofloxacin; ciprofloxacin hydrochloride. It is used in urinary tract infection. Currently, eHealthMe is studying from 76 Ciprofloxacin extended release users.

Number of Ciprofloxacin extended release reports submitted per year:

Ciprofloxacin extended release side effects.

Ciprofloxacin Extended Release side effects by time on the drug*:

< 1 month:

  1. Tendonitis (a condition that causes pain and swelling of tendons)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Death
  2. Tendon disorder (disease of tendon)
  3. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  4. Nephritis allergic (inflammation of nephrons due to allergen)
  5. Aspergillosis (an infection caused by a fungus called aspergillus)
  6. Bradycardia (abnormally slow heart action)
  7. Cardiac failure
  8. Colitis ulcerative (inflammation of colon with ulcer)
  9. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  10. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)

Ciprofloxacin Extended Release side effects by gender *:

female:

n/a

male:

  1. Tendonitis (a condition that causes pain and swelling of tendons)

Ciprofloxacin Extended Release side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Tendonitis (a condition that causes pain and swelling of tendons)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Ciprofloxacin extended release?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on ciprofloxacin; ciprofloxacin hydrochloride (the active ingredients of Ciprofloxacin extended release) and Ciprofloxacin extended release (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Ciprofloxacin extended release:

All Ciprofloxacin extended release side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: